HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $152 Price Target
10/13/2026
Impact: 70
Healthcare
HC Wainwright & Co. analyst Mitchell S. Kapoor has reiterated a Buy rating on Incyte (NASDAQ: INCY) and maintained a price target of $152 for the stock.
AI summary, not financial advice
Share: